Matthias Karer

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible <i>Staphylococcus aureus</i> during treatment of a cardiac device-related endocarditis

Manuel Kussmann, Matthias Karer, Markus Obermueller et al. · Emerging Microbes & Infections · 2018 · 71 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Extracellular Vesicles and Citrullinated Histone H3 in Coronavirus Disease 2019 Patients

Ludwig Traby, Marietta Kollars, Manuel Kussmann et al. · Thrombosis and Haemostasis · 2021 · 35 citations

Life Sciences, Immunology, Infectious Diseases +12

Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease

Ursula Lemberger, Claudia Fuchs, Matthias Karer et al. · Oncotarget · 2016 · 18 citations · Full text

Medicine, Pathobiology, Pharmacology +13

Comparison of non-invasive Staphylococcus aureus sampling methods on lesional skin in patients with atopic dermatitis

Heimo Lagler, Christine Bangert, Tamara Quint et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2021 · 14 citations · Full text

Medicine, Dermatology, Infectious Diseases +15

Simple, sensitive and specific quantification of diamine oxidase activity in complex matrices using newly discovered fluorophores derived from natural substrates

Thomas Boehm, Matthias Karer, Elisabeth Gludovacz et al. · Inflammation Research · 2020 · 13 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17